Pure Global

Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT) - UK MHRA Medical Device Registration

Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 149483. The device is manufactured by Predicine, Inc. from United States, classified as In Vitro Diagnostic Device. The authorized representative in the UK is KINGSMEAD SERVICE LIMITED.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
MHRA Registered
In Vitro Diagnostic Device
๐Ÿ‡ฌ๐Ÿ‡ง
Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)
MHRA Device ID: 149483โ€ขRef: 149483

Device Type

In Vitro Diagnostic Device

Devices

Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)

Type

IVD General

Date Registered

Nov 26, 2024

Last Updated

Jan 25, 2024

Manufacturer Information

Address

3555 Arden Road

Hayward, CA, United States

Created Date

Jun 10, 2022

Authorized Representative

Relationship Type

UK Responsible Person

Address

19 MEZZANINE FLOOR 19-21 CRAWFORD STREET

London, England, United Kingdom

Postcode: W1H 1PJ

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing